Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Infrequent HIV infection of circulating monocytes during antiretroviral therapy.

Massanella M, Bakeman W, Sithinamsuwan P, Fletcher JLK, Chomchey N, Tipsuk S, Chalermchai T, Routy JP, Ananworanich J, Valcour VG, Chomont N; SEARCH 011 Study Group.

J Virol. 2019 Oct 9. pii: JVI.01174-19. doi: 10.1128/JVI.01174-19. [Epub ahead of print]

PMID:
31597764
2.

Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy.

Christensen-Quick A, Massanella M, Frick A, Rawlings SA, Spina C, Vargas-Meneses M, Schrier R, Nakazawa M, Anderson C, Gianella S.

J Virol. 2019 Jun 14;93(13). pii: e00179-19. doi: 10.1128/JVI.00179-19. Print 2019 Jul 1.

PMID:
31019052
3.

Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size.

Rosenbloom DIS, Bacchetti P, Stone M, Deng X, Bosch RJ, Richman DD, Siliciano JD, Mellors JW, Deeks SG, Ptak RG, Hoh R, Keating SM, Dimapasoc M, Massanella M, Lai J, Sobolewski MD, Kulpa DA, Busch MP; Reservoir Assay Validation and Evaluation Network (RAVEN) Study Group.

PLoS Comput Biol. 2019 Apr 12;15(4):e1006849. doi: 10.1371/journal.pcbi.1006849. eCollection 2019 Apr.

4.

Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection.

Pardons M, Baxter AE, Massanella M, Pagliuzza A, Fromentin R, Dufour C, Leyre L, Routy JP, Kaufmann DE, Chomont N.

PLoS Pathog. 2019 Feb 27;15(2):e1007619. doi: 10.1371/journal.ppat.1007619. eCollection 2019 Feb.

5.

Replication competence of virions induced from CD4+ lymphocytes latently infected with HIV.

Richman DD, Huang K, Lada SM, Sun X, Jain S, Massanella M, Menke B.

Retrovirology. 2019 Feb 15;16(1):4. doi: 10.1186/s12977-019-0466-1.

6.

Improved assays to measure and characterize the inducible HIV reservoir.

Massanella M, Yek C, Lada SM, Nakazawa M, Shefa N, Huang K, Richman DD.

EBioMedicine. 2018 Oct;36:113-121. doi: 10.1016/j.ebiom.2018.09.036. Epub 2018 Oct 11.

7.

Analyses of Mitochondrial DNA and Immune Phenotyping Suggest Accelerated T-Cell Turnover in Treated HIV.

Massanella M, Karris MY, Pérez-Santiago J, Yek C, Vitomirov A, Mehta SR.

J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):399-406. doi: 10.1097/QAI.0000000000001824.

PMID:
30312276
8.

Inducible HIV RNA transcription assays to measure HIV persistence: pros and cons of a compromise.

Plantin J, Massanella M, Chomont N.

Retrovirology. 2018 Jan 17;15(1):9. doi: 10.1186/s12977-017-0385-y. Review.

9.

Memory B cell dysregulation in HIV-1-infected individuals.

Carrillo J, Negredo E, Puig J, Molinos-Albert LM, Rodríguez de la Concepción ML, Curriu M, Massanella M, Navarro J, Crespo M, Viñets E, Millá F, Clotet B, Blanco J.

AIDS. 2018 Jan 14;32(2):149-160. doi: 10.1097/QAD.0000000000001686.

PMID:
29112067
10.

Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery.

Gómez-Mora E, Massanella M, García E, Giles D, Bernadó M, Urrea V, Carrillo J, Ouchi D, Puig J, Negredo E, Clotet B, Blanco J, Cabrera C.

PLoS One. 2017 Sep 21;12(9):e0184433. doi: 10.1371/journal.pone.0184433. eCollection 2017.

11.

Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recovery.

Gómez-Mora E, García E, Urrea V, Massanella M, Puig J, Negredo E, Clotet B, Blanco J, Cabrera C.

Sci Rep. 2017 Sep 15;7(1):11711. doi: 10.1038/s41598-017-12013-2.

12.

Multiparametric characterization of rare HIV-infected cells using an RNA-flow FISH technique.

Baxter AE, Niessl J, Fromentin R, Richard J, Porichis F, Massanella M, Brassard N, Alsahafi N, Routy JP, Finzi A, Chomont N, Kaufmann DE.

Nat Protoc. 2017 Oct;12(10):2029-2049. doi: 10.1038/nprot.2017.079. Epub 2017 Sep 7.

13.

Evaluation of the Aptima HIV-1 Quant Dx Assay for HIV-1 RNA Quantitation in Different Biological Specimen Types.

Yek C, Massanella M, Peling T, Lednovich K, Nair SV, Worlock A, Vargas M, Gianella S, Ellis RJ, Strain MC, Busch MP, Nugent CT, Richman DD.

J Clin Microbiol. 2017 Aug;55(8):2544-2553. doi: 10.1128/JCM.00425-17. Epub 2017 Jun 7.

14.

Brief Report: Impaired CD4 T-Cell Response to Autophagy in Treated HIV-1-Infected Individuals.

Gómez-Mora E, Robert-Hebmann V, García E, Massanella M, Clotet B, Cabrera C, Blanco J, Biard-Piechaczyk M.

J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):201-205. doi: 10.1097/QAI.0000000000001201.

PMID:
27787338
15.

Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals.

Baxter AE, Niessl J, Fromentin R, Richard J, Porichis F, Charlebois R, Massanella M, Brassard N, Alsahafi N, Delgado GG, Routy JP, Walker BD, Finzi A, Chomont N, Kaufmann DE.

Cell Host Microbe. 2016 Sep 14;20(3):368-380. doi: 10.1016/j.chom.2016.07.015. Epub 2016 Aug 18.

16.

Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.

Puertas MC, Noguera-Julian M, Massanella M, Pou C, Buzon MJ, Clotet B, Stevenson M, Paredes R, Blanco J, Martinez-Picado J.

Retrovirology. 2016 Aug 2;13(1):51. doi: 10.1186/s12977-016-0282-9.

17.

Standard vaccines increase HIV-1 transcription during antiretroviral therapy.

Yek C, Gianella S, Plana M, Castro P, Scheffler K, García F, Massanella M, Smith DM.

AIDS. 2016 Sep 24;30(15):2289-98. doi: 10.1097/QAD.0000000000001201.

18.

Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes.

Pérez-Santiago J, Ouchi D, Urrea V, Carrillo J, Cabrera C, Villà-Freixa J, Puig J, Paredes R, Negredo E, Clotet B, Massanella M, Blanco J.

AIDS. 2016 Sep 24;30(15):2275-87. doi: 10.1097/QAD.0000000000001205.

19.

Replication of Human Herpesviruses Is Associated with Higher HIV DNA Levels during Antiretroviral Therapy Started at Early Phases of HIV Infection.

Gianella S, Anderson CM, Var SR, Oliveira MF, Lada SM, Vargas MV, Massanella M, Little SJ, Richman DD, Strain MC, Pérez-Santiago J, Smith DM.

J Virol. 2016 Mar 28;90(8):3944-3952. doi: 10.1128/JVI.02638-15. Print 2016 Apr.

20.

Measuring the latent reservoir in vivo.

Massanella M, Richman DD.

J Clin Invest. 2016 Feb;126(2):464-72. doi: 10.1172/JCI80567. Epub 2016 Feb 1. Review.

21.

Brief Report: Effect of CMV and HIV Transcription on CD57 and PD-1 T-Cell Expression During Suppressive ART.

Dan JM, Massanella M, Smith DM, Spina CA, Schrier R, Daar ES, Dube MP, Morris SR, Gianella S.

J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):133-7. doi: 10.1097/QAI.0000000000000936.

22.

Residual inflammation and viral reservoirs: alliance against an HIV cure.

Massanella M, Fromentin R, Chomont N.

Curr Opin HIV AIDS. 2016 Mar;11(2):234-41. doi: 10.1097/COH.0000000000000230. Review.

23.

Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection.

Pérez-Santiago J, Schrier RD, de Oliveira MF, Gianella S, Var SR, Day TR, Ramirez-Gaona M, Suben JD, Murrell B, Massanella M, Cherner M, Smith DM, Ellis RJ, Letendre SL, Mehta SR.

J Neurovirol. 2016 Apr;22(2):191-200. doi: 10.1007/s13365-015-0384-5. Epub 2015 Oct 1.

24.

Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy.

Massanella M, Gianella S, Schrier R, Dan JM, Pérez-Santiago J, Oliveira MF, Richman DD, Little SJ, Benson CA, Daar ES, Dube MP, Haubrich RH, Smith DM, Morris SR.

Sci Rep. 2015 Aug 24;5:13179. doi: 10.1038/srep13179.

25.

Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery.

Massanella M, Gómez-Mora E, Carrillo J, Curriu M, Ouchi D, Puig J, Negredo E, Cabrera C, Clotet B, Blanco J.

J Transl Med. 2015 Jul 17;13:230. doi: 10.1186/s12967-015-0601-2.

26.

Quantification of Total and 2-LTR (Long terminal repeat) HIV DNA, HIV RNA and Herpesvirus DNA in PBMCs.

Massanella M, Gianella S, Lada SM, Richman DD, Strain MC.

Bio Protoc. 2015 Jun 5;5(11). pii: e1492.

27.

Quantification of HIV RNA and Human Herpesvirus DNA in Seminal Plasma.

Vargas-Meneses MV, Massanella M, Ignacio CC, Gianella S.

Bio Protoc. 2015 May 5;5(9). pii: e1465.

28.

The Sordid Affair Between Human Herpesvirus and HIV.

Gianella S, Massanella M, Wertheim JO, Smith DM.

J Infect Dis. 2015 Sep 15;212(6):845-52. doi: 10.1093/infdis/jiv148. Epub 2015 Mar 6. Review.

29.

Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals.

Massanella M, Ouchi D, Marfil S, Llibre JM, Puertas MC, Buzón MJ, Richman DD, Orna E, Stevenson M, Gatell JM, Domingo P, Negredo E, Martinez-Picado J, Clotet B, Blanco J.

PLoS One. 2014 Dec 2;9(12):e114142. doi: 10.1371/journal.pone.0114142. eCollection 2014.

30.

Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment.

Gianella S, Massanella M, Richman DD, Little SJ, Spina CA, Vargas MV, Lada SM, Daar ES, Dube MP, Haubrich RH, Morris SR, Smith DM; California Collaborative Treatment Group 592 Team.

J Virol. 2014 Jul;88(14):7818-27. doi: 10.1128/JVI.00831-14. Epub 2014 Apr 30.

31.

Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection.

Puertas MC, Massanella M, Llibre JM, Ballestero M, Buzon MJ, Ouchi D, Esteve A, Boix J, Manzardo C, Miró JM, Gatell JM, Clotet B, Blanco J, Martinez-Picado J; MaraviBoost Collaborative Group.

AIDS. 2014 Jan 28;28(3):325-34. doi: 10.1097/QAD.0000000000000066.

PMID:
24185044
32.

Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection.

Pérez-Santiago J, Gianella S, Massanella M, Spina CA, Karris MY, Var SR, Patel D, Jordan PS, Young JA, Little SJ, Richman DD, Smith DM.

AIDS. 2013 Jul 31;27(12):1921-31.

33.

Immunodiscordant responses to HAART--mechanisms and consequences.

Massanella M, Negredo E, Clotet B, Blanco J.

Expert Rev Clin Immunol. 2013 Nov;9(11):1135-49. doi: 10.1586/1744666X.2013.842897. Review.

PMID:
24168417
34.

The effect of cell subset isolation method on gene expression in leukocytes.

Beliakova-Bethell N, Massanella M, White C, Lada S, Du P, Vaida F, Blanco J, Spina CA, Woelk CH.

Cytometry A. 2014 Jan;85(1):94-104. doi: 10.1002/cyto.a.22352. Epub 2013 Sep 20.

35.

HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoprotein.

Carrillo J, Restrepo C, Rallón NI, Massanella M, del Romero J, Rodríguez C, Soriano V, Clotet B, Benito JM, Blanco J.

AIDS. 2013 Jun 1;27(9):1375-85. doi: 10.1097/QAD.0b013e32835fac08.

PMID:
23945502
36.

Differential gene expression in HIV-infected individuals following ART.

Massanella M, Singhania A, Beliakova-Bethell N, Pier R, Lada SM, White CH, Pérez-Santiago J, Blanco J, Richman DD, Little SJ, Woelk CH.

Antiviral Res. 2013 Nov;100(2):420-8. doi: 10.1016/j.antiviral.2013.07.017. Epub 2013 Aug 6.

37.

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.

Negredo E, Massanella M, Puertas MC, Buzón MJ, Puig J, Pérez-Alvárez N, Pérez-Santiago J, Bonjoch A, Moltó J, Jou A, Echeverría P, Llibre JM, Martínez-Picado J, Clotet B, Blanco J.

J Antimicrob Chemother. 2013 Oct;68(10):2358-62. doi: 10.1093/jac/dkt183. Epub 2013 May 14.

38.

Assessing main death pathways in T lymphocytes from HIV infected individuals.

Massanella M, Curriu M, Carrillo J, Gómez E, Puig J, Navarro J, Dalmau J, Martínez-Picado J, Crespo M, Cabrera C, Negredo E, Clotet B, Blanco J.

Cytometry A. 2013 Jul;83(7):648-58. doi: 10.1002/cyto.a.22299. Epub 2013 May 6.

39.

Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome.

Curriu M, Carrillo J, Massanella M, Rigau J, Alegre J, Puig J, Garcia-Quintana AM, Castro-Marrero J, Negredo E, Clotet B, Cabrera C, Blanco J.

J Transl Med. 2013 Mar 20;11:68. doi: 10.1186/1479-5876-11-68.

40.

Dynamics of CD8 T-cell activation after discontinuation of HIV treatment intensification.

Massanella M, Esteve A, Buzón MJ, Llibre JM, Puertas MC, Gatell JM, Domingo P, Stevenson M, Clotet B, Martinez-Picado J, Blanco J; IntegRal Collaborative Group.

J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):152-60. doi: 10.1097/QAI.0b013e318289439a.

PMID:
23392458
41.

Attacking the HIV reservoir from the immune and viral perspective.

Massanella M, Martinez-Picado J, Blanco J.

Curr HIV/AIDS Rep. 2013 Mar;10(1):33-41. doi: 10.1007/s11904-012-0150-8. Review.

PMID:
23242702
42.

Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals.

Casanova V, Naval-Macabuhay I, Massanella M, Rodríguez-García M, Blanco J, Gatell JM, García F, Gallart T, Lluis C, Mallol J, Franco R, Climent N, McCormick PJ.

PLoS One. 2012;7(12):e51287. doi: 10.1371/journal.pone.0051287. Epub 2012 Dec 11.

43.

Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery.

Massanella M, Negredo E, Puig J, Puertas MC, Buzón MJ, Pérez-Álvarez N, Carrillo J, Clotet B, Martínez-Picado J, Blanco J.

AIDS. 2012 Nov 28;26(18):2285-93. doi: 10.1097/QAD.0b013e328359f20f.

PMID:
23018435
44.

Susceptibility of human lymphoid tissue cultured ex vivo to xenotropic murine leukemia virus-related virus (XMRV) infection.

Curriu M, Carrillo J, Massanella M, Garcia E, Cunyat F, Peña R, Wienberg P, Carrato C, Areal J, Bofill M, Clotet B, Blanco J, Cabrera C.

PLoS One. 2012;7(5):e37415. doi: 10.1371/journal.pone.0037415. Epub 2012 May 16.

45.

Viremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and function.

Curriu M, Fausther-Bovendo H, Pernas M, Massanella M, Carrillo J, Cabrera C, López-Galíndez C, Clotet B, Debré P, Vieillard V, Blanco J.

PLoS One. 2012;7(2):e30330. doi: 10.1371/journal.pone.0030330. Epub 2012 Feb 1.

46.

Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study.

Llibre JM, Buzón MJ, Massanella M, Esteve A, Dahl V, Puertas MC, Domingo P, Gatell JM, Larrouse M, Gutierrez M, Palmer S, Stevenson M, Blanco J, Martinez-Picado J, Clotet B.

Antivir Ther. 2012;17(2):355-64. doi: 10.3851/IMP1917. Epub 2011 Sep 28.

PMID:
22290239
47.

Deep molecular characterization of HIV-1 dynamics under suppressive HAART.

Buzón MJ, Codoñer FM, Frost SD, Pou C, Puertas MC, Massanella M, Dalmau J, Llibre JM, Stevenson M, Blanco J, Clotet B, Paredes R, Martinez-Picado J.

PLoS Pathog. 2011 Oct;7(10):e1002314. doi: 10.1371/journal.ppat.1002314. Epub 2011 Oct 27.

48.

A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity.

Sánchez-Palomino S, Massanella M, Carrillo J, García A, García F, González N, Merino A, Alcamí J, Bofill M, Yuste E, Gatell JM, Clotet B, Blanco J.

Vaccine. 2011 Jul 18;29(32):5250-9. doi: 10.1016/j.vaccine.2011.05.016. Epub 2011 May 24.

PMID:
21609746
49.

Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque.

Rotger M, Dalmau J, Rauch A, McLaren P, Bosinger SE, Martinez R, Sandler NG, Roque A, Liebner J, Battegay M, Bernasconi E, Descombes P, Erkizia I, Fellay J, Hirschel B, Miró JM, Palou E, Hoffmann M, Massanella M, Blanco J, Woods M, Günthard HF, de Bakker P, Douek DC, Silvestri G, Martinez-Picado J, Telenti A.

J Clin Invest. 2011 Jun;121(6):2391-400. doi: 10.1172/JCI45235. Epub 2011 May 9.

50.

The reconstitution of the thymus in immunosuppressed individuals restores CD4-specific cellular and humoral immune responses.

Plana M, Garcia F, Darwich L, Romeu J, López A, Cabrera C, Massanella M, Canto E, Ruiz-Hernandez R, Blanco J, Sánchez M, Gatell JM, Clotet B, Ruiz L, Bofill M; Red de Investigación en Sida (RIS).

Immunology. 2011 Jul;133(3):318-28. doi: 10.1111/j.1365-2567.2011.03442.x. Epub 2011 Apr 19.

Supplemental Content

Loading ...
Support Center